Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

NYSE:VYX - New York Stock Exchange, Inc. - US62886E1082 - Common Stock - Currency: USD

14.47  +0.04 (+0.28%)

Fundamental Rating

3

VYX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. While VYX is still in line with the averages on profitability rating, there are concerns on its financial health. VYX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

VYX had positive earnings in the past year.
VYX had a negative operating cash flow in the past year.
In multiple years VYX reported negative net income over the last 5 years.
Of the past 5 years VYX 4 years had a positive operating cash flow.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

VYX has a Return On Assets of 21.26%. This is amongst the best in the industry. VYX outperforms 95.74% of its industry peers.
VYX has a better Return On Equity (81.38%) than 97.52% of its industry peers.
VYX has a better Return On Invested Capital (1.21%) than 65.96% of its industry peers.
Industry RankSector Rank
ROA 21.26%
ROE 81.38%
ROIC 1.21%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

The Profit Margin of VYX (26.78%) is better than 92.91% of its industry peers.
In the last couple of years the Profit Margin of VYX has grown nicely.
VYX's Operating Margin of 1.31% is fine compared to the rest of the industry. VYX outperforms 64.54% of its industry peers.
VYX's Operating Margin has declined in the last couple of years.
VYX's Gross Margin of 20.74% is on the low side compared to the rest of the industry. VYX is outperformed by 81.91% of its industry peers.
In the last couple of years the Gross Margin of VYX has declined.
Industry RankSector Rank
OM 1.31%
PM (TTM) 26.78%
GM 20.74%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

VYX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VYX has been reduced compared to 1 year ago.
Compared to 5 years ago, VYX has more shares outstanding
The debt/assets ratio for VYX has been reduced compared to a year ago.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.41, we must say that VYX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.41, VYX is in line with its industry, outperforming 40.07% of the companies in the same industry.
VYX has a Debt/Equity ratio of 0.97. This is a neutral value indicating VYX is somewhat dependend on debt financing.
VYX's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. VYX is outperformed by 72.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACC0.11
WACC11.24%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.12. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of VYX (1.12) is worse than 68.44% of its industry peers.
A Quick Ratio of 0.96 indicates that VYX may have some problems paying its short term obligations.
VYX has a worse Quick ratio (0.96) than 75.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.96
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

VYX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -66.67%.
VYX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.03% yearly.
The Revenue for VYX has decreased by -60.40% in the past year. This is quite bad
The Revenue for VYX have been decreasing by -16.39% on average. This is quite bad
EPS 1Y (TTM)-66.67%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-60.4%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-28.42%

3.2 Future

Based on estimates for the next years, VYX will show a very strong growth in Earnings Per Share. The EPS will grow by 34.08% on average per year.
The Revenue is expected to decrease by -9.14% on average over the next years.
EPS Next Y79.05%
EPS Next 2Y49%
EPS Next 3Y34.08%
EPS Next 5YN/A
Revenue Next Year-9.04%
Revenue Next 2Y-11.79%
Revenue Next 3Y-9.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

VYX is valuated quite expensively with a Price/Earnings ratio of 36.17.
Based on the Price/Earnings ratio, VYX is valued a bit cheaper than 67.38% of the companies in the same industry.
When comparing the Price/Earnings ratio of VYX to the average of the S&P500 Index (27.53), we can say VYX is valued slightly more expensively.
A Price/Forward Earnings ratio of 14.81 indicates a correct valuation of VYX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 86.88% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.71, VYX is valued rather cheaply.
Industry RankSector Rank
PE 36.17
Fwd PE 14.81
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 95.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.83
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

VYX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VYX's earnings are expected to grow with 34.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y49%
EPS Next 3Y34.08%

0

5. Dividend

5.1 Amount

VYX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NCR VOYIX CORP

NYSE:VYX (7/23/2025, 12:05:26 PM)

14.47

+0.04 (+0.28%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-05 2025-08-05
Inst Owners113.37%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner Change21.09%
Market Cap1.99B
Analysts85
Price Target15.56 (7.53%)
Short Float %13.82%
Short Ratio10.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP1.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)147.53%
Min EPS beat(2)55.59%
Max EPS beat(2)239.46%
EPS beat(4)3
Avg EPS beat(4)87.32%
Min EPS beat(4)-45.76%
Max EPS beat(4)239.46%
EPS beat(8)5
Avg EPS beat(8)35.38%
EPS beat(12)8
Avg EPS beat(12)25.97%
EPS beat(16)10
Avg EPS beat(16)17.12%
Revenue beat(2)1
Avg Revenue beat(2)-0.36%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)0.95%
Revenue beat(4)2
Avg Revenue beat(4)-4.57%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)1.8%
Revenue beat(8)3
Avg Revenue beat(8)10.83%
Revenue beat(12)5
Avg Revenue beat(12)7.13%
Revenue beat(16)6
Avg Revenue beat(16)4.63%
PT rev (1m)7.02%
PT rev (3m)-3.94%
EPS NQ rev (1m)-1.89%
EPS NQ rev (3m)-10.38%
EPS NY rev (1m)0.43%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)2.74%
Valuation
Industry RankSector Rank
PE 36.17
Fwd PE 14.81
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 1.76
P/tB N/A
EV/EBITDA 7.83
EPS(TTM)0.4
EY2.76%
EPS(NY)0.98
Fwd EY6.75%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-1.01
OCFYN/A
SpS24.99
BVpS8.23
TBVpS-3.45
PEG (NY)0.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 21.26%
ROE 81.38%
ROCE 1.54%
ROIC 1.21%
ROICexc 1.51%
ROICexgc 4.75%
OM 1.31%
PM (TTM) 26.78%
GM 20.74%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-36.27%
ROICexcg growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 3.42
Cap/Depr 70.65%
Cap/Sales 5.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.96
Altman-Z 1.41
F-Score5
WACC11.24%
ROIC/WACC0.11
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-30.77%
EPS Next Y79.05%
EPS Next 2Y49%
EPS Next 3Y34.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-60.4%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-28.42%
Revenue Next Year-9.04%
Revenue Next 2Y-11.79%
Revenue Next 3Y-9.14%
Revenue Next 5YN/A
EBIT growth 1Y-93.3%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year376.67%
EBIT Next 3Y74.29%
EBIT Next 5Y46.94%
FCF growth 1Y-203.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.74%
OCF growth 3YN/A
OCF growth 5YN/A